Cerus (CERS) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cerus | 549.42 Mn | 469.73 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.99% |
| Dec 31, 2025 | -7.87% |
| Sep 30, 2025 | -14.32% |
| Mar 31, 2025 | -13.62% |
| Dec 31, 2024 | -13.65% |
| Sep 30, 2024 | -13.34% |
| Jun 30, 2024 | -12.70% |
| Mar 31, 2024 | -12.83% |
| Dec 31, 2023 | 1.22% |
| Sep 30, 2023 | 24.25% |
| Jun 30, 2023 | 36.59% |
| Mar 31, 2023 | 40.63% |
| Dec 31, 2022 | 38.93% |
| Sep 30, 2022 | 35.37% |
| Jun 30, 2022 | 33.18% |
| Mar 31, 2022 | 32.62% |
| Dec 31, 2021 | 32.54% |
| Sep 30, 2021 | 31.66% |
| Jun 30, 2021 | 31.84% |
| Mar 31, 2021 | 31.48% |
| Dec 31, 2020 | 31.33% |
| Sep 30, 2020 | 30.89% |
| Mar 31, 2020 | 31.01% |
| Dec 31, 2019 | 31.55% |
| Sep 30, 2019 | 31.42% |
| Jun 30, 2019 | 33.53% |
| Mar 31, 2019 | 38.42% |
| Dec 31, 2018 | 30.01% |
| Sep 30, 2018 | 11.07% |
| Jun 30, 2018 | 5.62% |
| Mar 31, 2018 | 4.30% |
| Dec 31, 2017 | 4.53% |
| Sep 30, 2017 | 5.39% |
| Jun 30, 2017 | 7.45% |
| Mar 31, 2017 | 8.19% |
| Dec 31, 2016 | 8.00% |
| Sep 30, 2016 | 9.41% |
| Jun 30, 2016 | 8.48% |
| Dec 31, 2015 | 8.23% |